The “Blood-Grouping Reagents Market by End-user (hospitals and blood banks, clinical laboratories, and academic and research institutes) and Geography (North America, Europe, Asia, and Rest of World (ROW)) – Forecast and Analysis 2022-2026” report by Technavio considers the increasing prevalence of chronic disorders as one of the factors driving market growth. With ISO 9001:2015 certification, Technavio has been proudly partnering with more than 100 Fortune 500 companies for over 16 years.
The potential growth difference for the blood-grouping reagents market between 2021 and 2026 is USD 485.33 mn. To get the exact yearly growth variance and the Y-O-Y growth rate, Talk to our analyst.
Key Market Dynamics:
- Market Driver
- Market Challenges
The increasing prevalence of chronic disorders is one of the key factors driving growth the growth of the blood-grouping reagents market. In recent years, the increasing prevalence of diseases such as diabetes and cancer is leading to a rise in demand for early diagnosis for better patient care. In addition, chronic diseases such as cardiac diseases and diabetes are the leading cause of death and disability in the US. Blood group testing is needed for cancer patients who may require blood transfusion for treatment. Blood products such as platelets used for treating cancer patients have a short shelf life, which raises their demand. Doctors and surgeons need to identify the biochemical composition of blood group antigens of patients. Hence, the rise in the prevalence of chronic diseases, along with the demand for early diagnosis through blood grouping, has significantly led to the growth of the market.
The risks associated with blood transfusion will challenge the blood-grouping reagents market during the forecast period. Blood transfusion plays a major role in replacing the blood lost during surgeries, injuries, or chemotherapy drug effects among cancer patients. In addition, RBC, WBC, plasma, or platelet transfusions make patients susceptible to chronic diseases and bleeding disorders. However, this procedure involves the risk of complications during or post-transfusion, such as acute immune hemolytic reaction. Excessive blood transfusions also cause the buildup of a high amount of iron in the blood, which damages the liver, heart, and other parts of the body.
To learn about additional key drivers, trends, and challenges available with Technavio. Read our FREE Sample Report right now!
Market Segmentation
The blood-grouping reagents market is segmented by end-user into hospitals and blood banks, clinical laboratories, and academic and research institutes. The hospitals and blood banks segment will have significant market share growth during the forecast period. The high share is attributed to the high use of these reagents in hospitals and blood banks due to increased demand for blood transfusion.
By geography, the market has been segmented into North America, Europe, Asia, and Rest of World (ROW). North America will be the leading region with 46% of the market’s growth during the forecast period. The US and Canada are the key countries for the blood-grouping reagents in North America.
View our sample report for additional insights into the contribution of all the segments, and regional opportunities in the report.
Some Companies Mentioned
- Agena Bioscience Inc.
- Alpha Laboratories
- Arena BioScien
- Atlas Medical GmbH
- AXO Science
- BAG Health Care GmbH
- Beckman Coulter Inc.
- Bio Rad Laboratories Inc.
- DIAGAST SAS
- Grifols SA
- Haemokinesis Ltd.
- Immucor Inc.
- Lorne Laboratories Ltd.
- Medical Diagnostics Corp.
- Merck KGaA
- Novacyt SA
- Ortho-Clinical Diagnostics Inc.
- Quotient Ltd.
- Rapid Labs Ltd.
- Torax Biosciences Ltd.
- Tulip Diagnostics Pvt. Ltd.
- To gain access to more vendor profiles with their key offerings available with Technavio, Click Here
Related Reports:
Sequencing Reagents Market by Technology and Geography – Forecast and Analysis 2022-2026
Stem Cell Banking Market by Type and Geography – Forecast and Analysis 2021-2025
| Blood-Grouping Reagents Market Scope | |
| Report Coverage | Details |
| Page number | 120 |
| Base year | 2021 |
| Forecast period | 2022-2026 |
| Growth momentum & CAGR | Accelerate at a CAGR of 9.19% |
| Market growth 2022-2026 | USD 485.33 million |
| Market structure | Fragmented |
| YoY growth (%) | 7.31 |
| Regional analysis | North America, Europe, Asia, and Rest of World (ROW) |
| Performing market contribution | North America at 46% |
| Key consumer countries | US, Canada, UK, France, and Japan |
| Competitive landscape | Leading companies, competitive strategies, consumer engagement scope |
| Companies profiled | Agena Bioscience Inc., Alpha Laboratories, Arena BioScien, Atlas Medical GmbH, AXO Science, BAG Health Care GmbH, Beckman Coulter Inc., Bio Rad Laboratories Inc., DIAGAST SAS, Grifols SA, Haemokinesis Ltd., Immucor Inc., Lorne Laboratories Ltd., Medical Diagnostics Corp., Merck KGaA, Novacyt SA, Ortho-Clinical Diagnostics Inc., Quotient Ltd., Rapid Labs Ltd., Torax Biosciences Ltd., and Tulip Diagnostics Pvt. Ltd. |
| Market Dynamics | Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period. |
| Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
5 Market Segmentation by End-user
- 5.1 Market segments
- Exhibit 24: Chart on End-user – Market share 2021-2026 (%)
- Exhibit 25: Data Table on End-user – Market share 2021-2026 (%)
- 5.2 Comparison by End-user
- Exhibit 26: Chart on Comparison by End-user
- Exhibit 27: Data Table on Comparison by End-user
- 5.3 Hospitals and blood banks – Market size and forecast 2021-2026
- Exhibit 28: Chart on Hospitals and blood banks – Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Hospitals and blood banks – Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Hospitals and blood banks – Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Hospitals and blood banks – Year-over-year growth 2021-2026 (%)
- 5.4 Clinical Laboratories – Market size and forecast 2021-2026
- Exhibit 32: Chart on Clinical Laboratories – Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Clinical Laboratories – Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Clinical Laboratories – Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Clinical Laboratories – Year-over-year growth 2021-2026 (%)
- 5.5 Academic and research institutes – Market size and forecast 2021-2026
- Exhibit 36: Chart on Academic and research institutes – Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Academic and research institutes – Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Academic and research institutes – Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Academic and research institutes – Year-over-year growth 2021-2026 (%)
- 5.6 Market opportunity by End-user
- Exhibit 40: Market opportunity by End-user ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 42: Chart on Market share by geography 2021-2026 (%)
- Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 44: Chart on Geographic comparison
- Exhibit 45: Data Table on Geographic comparison
- 7.3 North America – Market size and forecast 2021-2026
- Exhibit 46: Chart on North America – Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on North America – Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on North America – Year-over-year growth 2021-2026 (%)
- 7.4 Europe – Market size and forecast 2021-2026
- Exhibit 50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Europe – Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
- 7.5 Asia – Market size and forecast 2021-2026
- Exhibit 54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Asia – Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
- Exhibit 58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
- 7.7 US – Market size and forecast 2021-2026
- Exhibit 62: Chart on US – Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on US – Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on US – Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on US – Year-over-year growth 2021-2026 (%)
- 7.8 UK – Market size and forecast 2021-2026
- Exhibit 66: Chart on UK – Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on UK – Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on UK – Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on UK – Year-over-year growth 2021-2026 (%)
- 7.9 Canada – Market size and forecast 2021-2026
- Exhibit 70: Chart on Canada – Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on Canada – Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Canada – Year-over-year growth 2021-2026 (%)
- 7.10 France – Market size and forecast 2021-2026
- Exhibit 74: Chart on France – Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on France – Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on France – Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on France – Year-over-year growth 2021-2026 (%)
- 7.11 Japan – Market size and forecast 2021-2026
- Exhibit 78: Chart on Japan – Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on Japan – Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on Japan – Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 82: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 83: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 85: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 86: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 87: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 88: Matrix on vendor position and classification
- 10.3 Atlas Medical GmbH
- Exhibit 89: Atlas Medical GmbH – Overview
- Exhibit 90: Atlas Medical GmbH – Product / Service
- Exhibit 91: Atlas Medical GmbH – Key offerings
- 10.4 Bio Rad Laboratories Inc.
- Exhibit 92: Bio Rad Laboratories Inc. – Overview
- Exhibit 93: Bio Rad Laboratories Inc. – Business segments
- Exhibit 94: Bio Rad Laboratories Inc. – Key news
- Exhibit 95: Bio Rad Laboratories Inc. – Key offerings
- Exhibit 96: Bio Rad Laboratories Inc. – Segment focus
- 10.5 DIAGAST SAS
- Exhibit 97: DIAGAST SAS – Overview
- Exhibit 98: DIAGAST SAS – Product / Service
- Exhibit 99: DIAGAST SAS – Key offerings
- 10.6 Grifols SA
- Exhibit 100: Grifols SA – Overview
- Exhibit 101: Grifols SA – Business segments
- Exhibit 102: Grifols SA – Key offerings
- Exhibit 103: Grifols SA – Segment focus
- 10.7 Immucor Inc.
- Exhibit 104: Immucor Inc. – Overview
- Exhibit 105: Immucor Inc. – Product / Service
- Exhibit 106: Immucor Inc. – Key offerings
- 10.8 Merck KGaA
- Exhibit 107: Merck KGaA – Overview
- Exhibit 108: Merck KGaA – Business segments
- Exhibit 109: Merck KGaA – Key news
- Exhibit 110: Merck KGaA – Key offerings
- Exhibit 111: Merck KGaA – Segment focus
- 10.9 Novacyt SA
- Exhibit 112: Novacyt SA – Overview
- Exhibit 113: Novacyt SA – Business segments
- Exhibit 114: Novacyt SA – Key offerings
- Exhibit 115: Novacyt SA – Segment focus
- 10.10 Ortho-Clinical Diagnostics Inc.
- Exhibit 116: Ortho-Clinical Diagnostics Inc. – Overview
- Exhibit 117: Ortho-Clinical Diagnostics Inc. – Product / Service
- Exhibit 118: Ortho-Clinical Diagnostics Inc. – Key offerings
- 10.11 Quotient Ltd.
- Exhibit 119: Quotient Ltd. – Overview
- Exhibit 120: Quotient Ltd. – Business segments
- Exhibit 121: Quotient Ltd. – Key news
- Exhibit 122: Quotient Ltd. – Key offerings
- Exhibit 123: Quotient Ltd. – Segment focus
- 10.12 Rapid Labs Ltd.
- Exhibit 124: Rapid Labs Ltd. – Overview
- Exhibit 125: Rapid Labs Ltd. – Product / Service
- Exhibit 126: Rapid Labs Ltd. – Key offerings
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 127: Inclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 128: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 129: Research methodology
- Exhibit 130: Validation techniques employed for market sizing
- Exhibit 131: Information sources
- 11.5 List of abbreviations
- Exhibit 132: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:[email protected]
Website: www.technavio.com/
SOURCE Technavio